Table 3.
East Africa 1968 pandemic influenza A (H3N2) articles included in review
| Article and study type | Location | Time period | Specimen collection definition | Outcome measured | Population | Pandemic H3N2 attack rate |
|---|---|---|---|---|---|---|
| • Montefiore D, et al., Trop Geogr Med. 1970 Mixed study design | Multiple locations in Uganda including prison, university, clinics, and hospitals | May 1969 to February 1970 | Undefined ILI among symptomatic persons No symptoms reported among single serology | Symptomatic influenza virus infection by culture AND/Or paired serology; and evidence of past influenza virus infection by single serology | 88 symptomatic prisoners with culture AND/OR paired serology | 100% viral culture (2/2), and 76% paired serology (67/88) |
| 12 symptomatic students with culture AND/OR paired serology | 25% viral culture (4/12), and 100% paired serology (11/11) | |||||
| 89 random dispensary patrons with single serology (at beginning of first pandemic wave) | 0% (0/89) | |||||
| 115 convenience sample of patients with blood drawn as part of unrelated study with single serology | 17% (19/115) | |||||
| 73 randomly selected staff embers and patients attending outpatient clinic with single serology | 22% (16/73) | |||||
| 49 randomly selected patients and staff at hospital in isolated community with single serology | 9% (4/49) | |||||
| 12 symptomatic patients with paired serology | 42% (5/12) | |||||
| • Montefiore D, et al.,Bull World Health Organ. 1970 Cross‐Sectional Survey | Hospitals in Kenya, Tanzania, and Uganda (two sites) | January to February 1970 | None reported | Evidence of past influenza virus infection by single serology | Randomly selected hospital patients with single serology | Kenya 37% (21/57); Tanzania 72% (65/90); Uganda 22% (16/73) and 8% (4/49) |
| • Salim AR. Bull World Health Organ. 1971 Prospective Cohort | University, Sudan | January 1970 | Undefined ILI | Symptomatic influenza virus infection by culture AND/OR paired serology | 33 symptomatic students with viral culture AND/OR paired serology | 27% viral culture (9/33); and 72% paired serology (18/25) |
| • Salim AR, Trop Geogr Med, 1974 Prospective Cohort | University and community, Sudan | Paired serology January to February 1970 Single serology May 1970 | For paired sera undefined ILI, and for complement fixing antibodies “blood draw for any clinical reason” | Symptomatic influenza virus infection by culture AND/Or paired serology; and evidence of past influenza virus infection by single serology | 50 symptomatic students with paired serology | 74% (37/50) |
| 192 convenience sample had single serology tested by complement fixation | 64% (123/192) | |||||
| • Anderson N, Trop Geogr Med, 1972 Cross‐Sectional Survey | Northern Kenya | July to August 1970 | None reported | Evidence of past influenza virus infection by single serology | 144 persons from two separate isolated villages | 41% (59/144) |
Paired serology, acute and convalescent sera; single serology, cross‐sectional single serum; ILI, influenza‐like illness. Geographic categories are based on United Nations geographic subregions. 49